Related Experiment Videos
Extraperitoneal Robot-Assisted Radical Prostatectomy: Indications, Technique and Outcomes
Alice Semerjian1, Christian P Pavlovich2
1James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Current Urology Reports
|April 19, 2017
Summary
Robot-assisted radical prostatectomy (eRARP) offers a safe alternative to transperitoneal RARP (tRARP) for prostate cancer. Extraperitoneal RARP is effective and adaptable, especially in challenging surgical situations.
Area of Science:
- Urology
- Surgical Oncology
- Robotic Surgery
Background:
- Extraperitoneal robot-assisted radical prostatectomy (eRARP) is an alternative to transperitoneal RARP (tRARP).
- eRARP offers a viable option for treating clinically localized prostate cancer.
Purpose of the Study:
- To review indications where eRARP is more favorable than tRARP.
- To discuss the safety and technique of eRARP.
Main Methods:
- Review of recently published comparative studies on eRARP and tRARP.
- Analysis of outcomes, safety, and specific indications for eRARP.
Main Results:
- eRARP is not inferior to tRARP in terms of outcomes and safety.
- eRARP may be preferred in specific circumstances, such as concomitant inguinal hernia repair.
- Urologists experienced with tRARP can adapt to the extraperitoneal approach.
Conclusions:
- Extraperitoneal robot-assisted radical prostatectomy is a safe and effective alternative to tRARP.
- eRARP is particularly useful in situations where tRARP might be challenging.
- Adaptation of eRARP is feasible for surgeons familiar with tRARP.